These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34111883)

  • 1. POSTOPERATIVE POSTERIOR SEGMENT COMPLICATIONS AFTER BOSTON TYPE 1 KERATOPROSTHESIS: Incidence, Risk Factors, and Intermediate-Term Outcomes.
    Bonnet C; Chehaibou I; Chen A; Bourges JL; Markovic D; Hubschman JP; Aldave AJ
    Retina; 2021 Dec; 41(12):2499-2509. PubMed ID: 34111883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
    Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
    Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious Keratitis After Boston Type 1 Keratoprosthesis Implantation.
    Ghaffari R; Bonnet C; Yung M; Bostan C; Harissi-Dagher M; Aldave AJ
    Cornea; 2021 Oct; 40(10):1298-1308. PubMed ID: 33630813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Vitritis after Boston Type 1 Keratoprosthesis Implantation: Incidence, Risk Factors and Outcomes in a Multicentric Cohort.
    Bonnet C; Chehaibou I; Ghaffari R; Jackson NJ; Bostan C; Hubschman JP; Harissi-Dagher M; Aldave AJ
    Ocul Immunol Inflamm; 2022 May; 30(4):769-775. PubMed ID: 33054501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
    Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
    Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endophthalmitis in Eyes With the Boston Type I Keratoprosthesis: Incidence, Recurrence, Risk Factors, and Outcomes.
    Bostan C; Nayman T; Szigiato AA; Morfeq H; Harissi-Dagher M
    Cornea; 2021 Oct; 40(10):1258-1266. PubMed ID: 33394754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
    Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
    Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis.
    Kaufman AR; Cruzat A; Colby KA
    Eye Contact Lens; 2018 Nov; 44(6):399-404. PubMed ID: 29219899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Outcomes of Pediatric Keratoprosthesis With the Near-Complete Conjunctival Flap.
    Bawany MH; Kudla C; Khan FA; Chung MM; Aquavella JV
    Cornea; 2021 Jun; 40(6):679-684. PubMed ID: 33941714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors, and treatment of retroprosthetic membranes following Boston keratoprosthesis eyes and the impact of glaucoma surgery.
    Gabriel BS; Robbins CB; Wisely CE; Gabriel RS; Daluvoy MB; Fekrat S
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2561-2567. PubMed ID: 38502349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.